Case Details

CourtDistrict of Delaware
Docket number1:13-cv-01220
Date case filed2013-07-10
Date case closed
Date of latest filing
Assigned toJudge Leonard P. Stark
Case cause35:271 Patent Infringement
Nature of suit830 Patent
Jury demandNone
Demand
JurisdictionFederal Question

Case Parties

Party: UCB Inc.
Party type: Counter Defendant
Attorney name: Jack B. Blumenfeld
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Maryellen Noreika
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: UCB Pharma GmbH
Party type: Counter Defendant
Attorney name: Jack B. Blumenfeld
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Maryellen Noreika
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Research Corporation Technologies Inc.
Party type: Plaintiff
Attorney name: Jack B. Blumenfeld
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Maryellen Noreika
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Harris FRC Corporation
Party type: Counter Defendant
Attorney name: Jack B. Blumenfeld
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Maryellen Noreika
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Zydus Pharmaceuticals (USA) Inc.
Party type: Counter Claimant
Attorney name: Francis J. Murphy , Jr.
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Cadila Healthcare Ltd.
Party type: Counter Claimant
doing business asZydus Cadila
Attorney name: Francis J. Murphy , Jr.
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Research Corporation Technologies Inc.
Party type: Counter Defendant
Attorney name: Jack B. Blumenfeld
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Maryellen Noreika
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Case Docket

Docket
Item
Date FiledDocument
Available
Short
Description
Long Description
12013-07-10 COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1326018.) - filed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/11/2013)
22013-07-10 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 07/11/2013)
32013-07-10 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/12/13. Date of Expiration of Patent: 3/17/22.Thirty Month Stay Deadline: 12/12/2015. (cla, ) (Entered: 07/11/2013)
42013-07-10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551;. (cla, ) (Entered: 07/11/2013)
52013-07-10 Disclosure Statement pursuant to Rule 7.1 filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH identifying Corporate Parent UCB S.A., Other Affiliate UCB Holdings Inc., Other Affiliate UCB Lux S.A., Other Affiliate Fipar US Inc., Other Affiliate Medeva Ltd. for UCB Inc.; Corporate Parent UCB GmbH, Other Affiliate UCB S.A., Other Affiliate UCB Finance N.V. for UCB Pharma GmbH. (cla, ) (Entered: 07/11/2013)
62013-07-19 REQUEST FOR WAIVER of Service sent to Zydus Pharmaceuticals (USA) Inc. on 7/11/2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/19/2013)
72013-07-19 WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/19/2013)
82013-07-19 REQUEST FOR WAIVER of Service sent to Cadila Healthcare Ltd. d/b/a Zydus Cadila on 7/11/13 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/19/2013)
92013-07-19 WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Cadila Healthcare Ltd. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/19/2013)
102013-08-02 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 14, 2013. Date of Expiration of Patent: March 17, 2022.Thirty Month Stay Deadline: 4/28/2016. (Noreika, Maryellen) (Entered: 08/02/2013)
112013-08-13 MOTION for Pro Hac Vice Appearance of Attorney Robert L. Baechtold, Scott K. Reed, Ha Kung Wong, Joshua I. Rothman, Fiona E. Darkin, Kimberley A. Gavin, Daniel J. Minion, John P. Dillon and Caitlin P. Hogan - filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. (Tigan, Jeremy) (Entered: 08/13/2013)
122013-09-09 ANSWER to 1 Complaint, , COUNTERCLAIM against Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd..(Murphy, Francis) (Entered: 09/09/2013)
132013-09-09 Disclosure Statement pursuant to Rule 7.1 filed by Cadila Healthcare Ltd.. (Murphy, Francis) (Entered: 09/09/2013)
142013-09-09 Disclosure Statement pursuant to Rule 7.1 filed by Zydus Pharmaceuticals (USA) Inc. identifying Corporate Parent Zydus International Pvt. Ltd. Ireland, Other Affiliate Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc., Zydus Pharmaceuticals (USA) Inc... (Murphy, Francis) (Entered: 09/09/2013)
152013-09-23 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Andrea L. Wayda - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit Certification by Counsel Michael M. Gaertner, Esq. to be admitted pro hac vice, # 2 Exhibit Certification by Counsel David B. Abramowitz, Esq. to be admitted pro hac vice, # 3 Exhibit Certification by Counsel Andrea L. Wayda, Esq. to be admitted pro hac vice)(Murphy, Francis) (Entered: 09/23/2013)
162013-09-30 ANSWER to 12 Answer to Complaint, Counterclaim by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 09/30/2013)
172013-12-10 ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal to the Court no later than January 6, 2014. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, Forms). ORDERED by Judge Leonard P. Stark on 12/10/13. Associated Cases: 1:13-cv-01148-LPS et al. (ntl) (Entered: 12/10/2013)
182014-01-06 PROPOSED ORDER (Scheduling) by Harris FRC Corporation, UCB Inc., UCB Pharma GmbH. (Attachments: # 1 Letter to the Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 01/06/2014)
192014-01-16 ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 28, 2014 at 9:45 a.m. Plaintiffs' counsel shall initiate the teleconference call to 302-573-4571. No further submissions are needed. ORDERED by Judge Leonard P. Stark on 1/16/14. Associated Cases: 1:13-cv-01148-LPS et al. (ntl) (Entered: 01/16/2014)
202014-01-29 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 01/29/2014)
212014-01-31 PROPOSED ORDER Scheduling by Breckenridge Pharmaceutical Inc., Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH, Vennoot Pharmaceuticals LLC, Sandoz Inc., Accord Healthcare Inc., Intas Pharmaceuticals Ltd., Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Apotex Corp., Apotex Inc., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Glenmark Generics Inc. USA, Glenmark Generics Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Alembic Limited, Alembic Pharmaceuticals Ltd., Hetero Labs Limited, Hetero USA Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Watson Laboratories Inc. - Florida, Watson Pharma Inc.. (Attachments: # 1 Letter)(Noreika, Maryellen) (Entered: 01/31/2014)
222014-02-07 Official Transcript of Telephone Conference on January 28, 2014 before Judge Leonard P. Stark. Court Reporter Brian P. Gaffigan, Telephone (302) 573-6360 Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/28/2014. Redacted Transcript Deadline set for 3/10/2014. Release of Transcript Restriction set for 5/8/2014. (bpg) (Entered: 02/07/2014)
232014-02-10 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for all purposes and all papers shall be filed in the Lead Case Civil Action No. 13-1206-LPS. Discovery due by 1/15/2015. Status Report due by 9/29/2014. Claim Construction Opening Brief due by 10/28/2014. Claim Construction Answering Brief due by 11/24/2014. A Markman Hearing is set for 12/15/2014 at 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Pretrial Conference is set for 10/22/2015 at 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 10/12/2015. A 5-day Bench Trial is set for 11/9/2015 at 09:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 2/7/14. (Attachments: # 1 Form of Pretrial Order) Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 02/10/2014)
242014-02-27 NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited; pursuant to Section 3 of this Courts Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Murphy, Francis) (Entered: 02/27/2014)
252014-02-28 NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (NOS. 1-64) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Murphy, Francis) (Entered: 02/28/2014)
262014-06-23 ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference is hereby re-scheduled for October 23, 2015 beginning at 9:00 a.m. ORDERED by Judge Leonard P. Stark on 6/23/14. Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 06/23/2014)
272015-11-20 Official Transcript of Pretrial Conference held on October 30, 2015 before Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/11/2015. Redacted Transcript Deadline set for 12/21/2015. Release of Transcript Restriction set for 2/18/2016. (bpg) (Entered: 11/20/2015)